EVH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EVH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Evolent Health's total equity for the quarter that ended in Dec. 2024 was $1,001 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
The historical data trend for Evolent Health's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Total Equity | Get a 7-Day Free Trial |
![]() |
![]() |
619.60 | 693.63 | 859.42 | 1,067.70 | 1,001.26 |
Evolent Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Total Equity | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
1,067.70 | 1,047.94 | 1,053.86 | 1,038.69 | 1,001.26 |
Total Equity and Total Liabilities are the two components for Total Assets.
Evolent Health's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as
Total Equity | = | Total Assets(Q: Dec. 2024 ) | - | Total Liabilities(Q: Dec. 2024 ) |
= | 2544.411 | - | 1543.152 | |
= | 1,001 |
Evolent Health's Total Equity for the quarter that ended in Dec. 2024 is calculated as
Total Equity | = | Total Assets(Q: Dec. 2024 ) | - | Total Liabilities(Q: Dec. 2024 ) |
= | 2544.411 | - | 1543.152 | |
= | 1,001 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Evolent Health's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard M Jelinek | director | 40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035 |
Kim Keck | director | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Peter J Grua | director | C/O HLM VENTURE PARTNERS, 800 SOUTH STREET, SUITE 620, WALTHAM MA 02453 |
Daniel Joseph Mccarthy | officer: PRESIDENT | 800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Craig A. Barbarosh | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Seth Blackley | officer: President | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Diane Holder | director | 800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
John Paul Johnson | officer: Chief Financial Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Emily Ann Rafferty | officer: Chief Operating Officer | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Jonathan Weinberg | officer: General Counsel | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Toyin Ajayi | director | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Cheryl Scott | director | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Mary Bridget Duffy | director | C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126 |
Frank J Williams | director, officer: Chief Executive Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Steve Tutewohl | officer: Chief Operating Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
From GuruFocus
By Business Wire • 11-07-2024
By GuruFocus News • 12-18-2024
By GuruFocus News • 11-12-2024
By GuruFocus News • 02-04-2025
By GuruFocus News • 02-22-2025
By GuruFocus News • 11-08-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 11-08-2024
By GuruFocus News • 01-14-2025
By PRNewswire • 01-27-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.